Results 31 to 40 of about 202,977 (306)
Frontiers in Digital Health, 2023 ObjectiveTo develop a simple and secure technological solution to incorporate electronic patient-reported outcomes (ePROs) into routine clinical care.MethodsA novel ePRO questionnaire delivery system was developed by Software for Specialists (S4S) in ...
Kathleen Tymms +17 more
doaj +1 more source
Rheumatologic emergencies [PDF]
Clinical Rheumatology, 2015 Rheumatological conditions can sometimes present as emergencies. These can occur due to the disease process or infection; contrary to what many people think, rheumatologic emergencies like a pain, rheumatic crisis, or attack gout do not compromise the patient's life.
openaire +3 more sources
The path towards the new strategic planning of PANLAR
Global Rheumatology, 2023 In this videoblog, Miguel Albanese, president of PANLAR, discusses the line of work proposed and the challenges for the future of society and research from PANLAR, with the main objective being the joint work between researchers, doctors and patients.
Estefania Fajardo , Miguel Albanese
doaj +1 more source
Prediction of drug effectiveness in rheumatoid arthritis patients based on machine learning algorithms [PDF]
arXiv, 2022 Rheumatoid arthritis (RA) is an autoimmune condition caused when patients' immune system mistakenly targets their own tissue. Machine learning (ML) has the potential to identify patterns in patient electronic health records (EHR) to forecast the best clinical treatment to improve patient outcomes.
arxiv
American Journal of Medical Genetics Part A, Volume 191, Issue 1, Page 37-51, January 2023., 2023 Abstract Vascular Ehlers–Danlos syndrome (vEDS) is a hereditary connective tissue disorder (HCTD) characterized by arterial dissection/aneurysm/rupture, sigmoid colon rupture, or uterine rupture. Diagnosis is confirmed by detecting heterozygous variants in COL3A1.
Tomomi Yamaguchi +25 more
wiley +1 more source
Global Rheumatology, 2022 "We are celebrating two years of officially launching Global Rheumatology, the new scientific journal for PANLAR. During this time, the emerging publication has consolidated its editorial policy with differential characteristics that meet the needs of ...
Carlo V Caballero-Uribe
doaj +1 more source
Pharmacological Research, 2019 Biotechnologicals are an invaluable resource in the treatment of patients with inflammatory rheumatic diseases (IRD) non-responsive or intolerant to conventional therapies. However, they are the main driver for increase in direct costs and represent a significant economic burden to healthcare systems worldwide.
Araújo, Filipe C. +2 more
openaire +3 more sources
MIF as an oncogenic driver of low‐heterogeneity melanomas
Molecular Oncology, EarlyView.Shvefel and colleagues identified tumor‐secreted macrophage migration inhibitory factor (MIF) as an upregulated cytokine that mediates immune resistance in melanomas with low‐intratumoral heterogeneity. MIF and its functional paralogue D‐dopachrome tautomerase (D‐DT or MIF‐2) have overlapping but nonidentical signaling functions and are hypothesized to
Thuy T. Tran +4 more
wiley +1 more source
Global Rheumatology, 2022 "Review Volume 4 of Global Rheumatology by Panlar from January to June 2022"
Global Rheumatology by PANLAR
doaj
Reumatismo, 2011 Nel precedente numero di questa rubrica riconoscevo la presenza di tre grossi limiti nella creazione dell’offerta di lavoro nel settore in Italia: • L’ignoranza da parte delle amministrazioni sanitarie delle dimensioni sociali, delle invalidità e dei costi derivanti dalle malattie reumatiche; • la mancanza di una vera concorrenza all’interno del ...
openaire +8 more sources